Pós Zoltán
Pós Zoltán
Assistant Professor, Dept. Of Genetics, Cell and Immunobiology, Semmelweis University
Verified email at med.semmelweis-univ.hu
TitleCited byYear
A human memory T cell subset with stem cell–like properties
L Gattinoni, E Lugli, Y Ji, Z Pos, CM Paulos, MF Quigley, JR Almeida, ...
Nature medicine 17 (10), 1290, 2011
Global analyses of human immune variation reveal baseline predictors of postvaccination responses
JS Tsang, PL Schwartzberg, Y Kotliarov, A Biancotto, Z Xie, RN Germain, ...
Cell 157 (2), 499-513, 2014
Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy
M Sabatino, S Kim-Schulze, MC Panelli, D Stroncek, E Wang, B Taback, ...
Journal of Clinical Oncology 27 (16), 2645, 2009
Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells
Y Ji, Z Pos, M Rao, CA Klebanoff, Z Yu, M Sukumar, RN Reger, ...
Nature immunology 12 (12), 1230, 2011
Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation
JB Szeberényi, É Pállinger, M Zsinkó, Z Pós, G Rothe, E Orsó, ...
Immunology letters 76 (3), 175-182, 2001
Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy
A Worschech, N Chen, AY Yong, Q Zhang, Z Pos, S Weibel, V Raab, ...
BMC genomics 10 (1), 301, 2009
Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation
A Falus, H Hegyesi, E Lázár-Molnár, Z Pós, V László, Z Darvas
Trends in immunology 22 (12), 648-652, 2001
Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine
K Boer, E Helinger, A Helinger, P Pocza, Z Pos, P Demeter, Z Baranyai, ...
European journal of cell biology 87 (4), 227-236, 2008
Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology
H Tahara, M Sato, M Thurin, E Wang, LH Butterfield, ML Disis, BA Fox, ...
Journal of translational medicine 7 (1), 45, 2009
Phenotypic profiling of engineered mouse melanomas with manipulated histamine production identifies histamine H2 receptor and rho-C as histamine-regulated melanoma progression …
Z Pós, G Sáfrány, K Müller, S Tóth, A Falus, H Hegyesi
Cancer research 65 (10), 4458-4466, 2005
Single-cell network profiling of peripheral blood mononuclear cells from healthy donors reveals age-and race-associated differences in immune signaling pathway activation
DM Longo, B Louie, S Putta, E Evensen, J Ptacek, J Cordeiro, E Wang, ...
The Journal of Immunology 188 (4), 1717-1725, 2012
The stable traits of melanoma genetics: an alternate approach to target discovery
TL Spivey, V De Giorgi, Y Zhao, D Bedognetti, Z Pos, Q Liu, S Tomei, ...
BMC genomics 13 (1), 156, 2012
Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma
Z Pos, Z Wiener, P Pocza, M Racz, S Toth, Z Darvas, V Molnar, H Hegyesi, ...
Cancer research 68 (6), 1997-2005, 2008
Molecular immune signatures of HIV‐1 vaccines in human PBMCs
A Monaco, FM Marincola, M Sabatino, Z Pos, ML Tornesello, DF Stroncek, ...
FEBS letters 583 (18), 3004-3008, 2009
Melanoma NOS1 expression promotes dysfunctional IFN signaling
Q Liu, S Tomei, ML Ascierto, V De Giorgi, D Bedognetti, C Dai, L Uccellini, ...
The Journal of clinical investigation 124 (5), 2147-2159, 2014
Histamine elevates the expression of Ets-1, a protooncogen in human melanoma cell lines through H2 receptor
H Hegyesi, B Horváth, É Pállinger, Z Pós, V Molnár, A Falus
FEBS letters 579 (11), 2475-2479, 2005
Histamine and cell proliferation
Z Pós, H Hegyesi, ES Rivera
Histamine: Biology and Medical Aspects. 1st ed. Budapest: SpringMed …, 2004
Spontaneous and treatment-induced cancer rejection in humans
E Wang, S Selleri, M Sabatino, A Monaco, Z Pos, A Worschech, ...
Expert opinion on biological therapy 8 (3), 337-349, 2008
Negative regulatory effect of histamine in DNFB-induced contact hypersensitivity
E Garaczi, M Széll, T Jánossy, A Koreck, A Pivarcsi, E Buzás, Z Pos, ...
International immunology 16 (12), 1781-1788, 2004
Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68
ML Ascierto, A Worschech, Z Yu, S Adams, J Reinboth, NG Chen, Z Pos, ...
BMC cancer 11 (1), 451, 2011
The system can't perform the operation now. Try again later.
Articles 1–20